Page last updated: 2024-09-05

sb 203580 and Hypereosinophilic Syndrome

sb 203580 has been researched along with Hypereosinophilic Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ip, WK; Lam, CW; Wong, CK1

Other Studies

1 other study(ies) available for sb 203580 and Hypereosinophilic Syndrome

ArticleYear
Tumour necrosis factor-alpha-induced expression of intercellular adhesion molecule-1 on human eosinophilic leukaemia EoL-1 cells is mediated by the activation of nuclear factor-kappaB pathway.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2003, Volume: 33, Issue:2

    Topics: Enzyme Inhibitors; Eosinophils; Gene Expression Regulation; Humans; Hypereosinophilic Syndrome; I-kappa B Proteins; Imidazoles; Intercellular Adhesion Molecule-1; Leupeptins; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Signal Transduction; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2003